December 2024
Dear readers,

after 5 years of ERNs it is time to look back and evaluate the work of ERNs - therefore the European Commission has organized a live webinar to present the results of the evaluation this Wednesday at 10 CET.

And we end the year 2024 with news on our updated disease knowledge concerning the clinical rating scales of Cervical Dystonia, MSA, PSP and Atypical PD, as well as an explanatory video on genetics and inheritance.

And as always you will find information on our upcoming webinars and events. Enjoy reading!

Best wishes,
The ERN-RND Coordination team

CONTENT

About us
Disease Knowledge
ERN-RND Webinars
Cross-border Health Care
ERN Video on Genetics and Inheritance
Upcoming Events

ABOUT US

This webinar will present the European Reference Network evaluation results report which has been published on 29 November 2024.


The report summarizes the results of a comprehensive evaluation of European Reference Networks (ERNs) and its members, five years after their creation, focusing on their role in addressing complex and rare conditions. 24 ERNs and 836 HCPs from 24 EU Member States and Norway participated in the evaluation. The evaluation included self-evaluations, document reviews, ERN interviews, on-site audits of members and stakeholder interviews.

For more information and registration click here.

DISEASE KNOWLEDGE

The Clinical Rating Scales for Cervical Dystonia as we all as MSA, PSP and Atypical PD have been updated and are availalble in 10 European languages.

For MSA, PSP and Atypical PD the Hoehn & Yahr Rating Scale has been added, for Dystonia it is the Modified Rankin Scale.

ERN-RND WEBINARS

Upcoming Joint Educational Webinars
ERN-RND provides free educational webinars on rare neurological and neuromuscular diseases - in collaboration with the European Reference Network for Rare Neuromuscular Diseases (EURO-NMD) and the European Academy of Neurology (EAN). The goal is to share knowledge on rare neurological, movement and neuromuscular disorders via a series of webinars presented by expert members of both networks.
05.12.2024, 4-5 pm CET | ‘The Role of Muscle Biopsy in Inflammatory Myopathies’ by Werner Stenzel, Charité – Universitätsmedizin Berlin Department of Neuropathology, Germany. SIGN UP here.

12.12.2024, 4-5 pm CET | ‘The Role of Biopsy in Congenital Myopathies’ by Norma Romero, Institute of Myology, Paris, France. SIGN UP here.

19.12.2024, 4-5 pm CET | ‘Novel Approaches and Future Developments in Neuromuscular Pathology’ by Edoardo Malfatti, Paris-Est AP-HP, France. SIGN UP here.

09.01.2025, 4-5 pm CET | ‘The Role of Biopsy in Autophagic Myopathies’ by Teresinha Evangelista, Institute of Myology & Pitié Salpêtrière Hospital – AP-HP, Paris, France. SIGN UP here.

16.01.2025, 4-5 pm CET | ‘The Role of Biopsy in Acquired Myopathies, other than Inflammatory Myopathies’ by Sarah Leonard-Louis, Pitié Salpêtrière Hospital – AP-HP, Paris, France. SIGN UP here.
eanCampus

eanCampus offers monthly webinars, 2 master classes per year and weekly podcasts on 3 expert levels (basic, advanced, expert), in total more than 1000 pieces. The next webinar will be on:


18.12.2024, 3-4 pm CET | ‘Neuromuscular Diseases’ by Mary Reilly (UK), Pamelia Evoly (Italy) and Jeff Allen (USA). SIGN UP here.

CROSS-BORDER HEALTH CARE

MLD Treatment Eligibility Panel
In cooperation with the MLD initiative, ERN-RND established a standard pathway for consulting an international MLD expert panel whenever possible benefits of treatment with hematopoietic stem cell transplantation or gene therapy are not straightforward for a patient with confirmed MLD diagnosis. Upon submission of an eligible case, the treatment eligibility panel is convened on an ad hoc basis, organized and supported by the ERN-RND CPMS helpdesk.

We encourage all physicians in Europe to discuss the possible benefits of treatment options for difficult cases with this MLD expert panel.

You would like to discuss one of your patients with the panel?

Please contact us.
Neuroradiology Expert Advice for Diagnostic and Management Decisions in RND

ERN-RND has established a standard pathway for providing expert neuroradiological advice across sites.
Our ERN-RND member hospitals (and affiliated partners) are encouraged to contact us for any RND case for which they would like a second opinion as a basis for individual recommendations for diagnostic and management strategies to optimize patient care.

Possible scenarios for which clinicians might want to use this offer include (but are not limited to):
  • Child with mild developmental delay: benign / onset of disease? -> cMRI: delayed brain maturation vs. (subtle) structural abnormalities
  • Child with delay + subtle signs: acquired / genetic? -> cMRI: acquired disease, e.g. CMV infection / TORCH vs. likely genetic
  • Acutely ill patients with suspected encephalopathy -> cMRI: secondary, e.g. infectious / para-infectious vs. metabolic / genetic
  • Cerebellar syndrome with fast progression -> cMRI: secondary, e.g., cerebellitis vs. genetic
  • Patient after pharmacological treatment showing brain volume reduction -> cMRI: side effects vs. neurodegenerative / neurogenetic disease

To make use of this opportunity, imaging data must be provided via CPMS. Advice will be provided in a virtual meeting between the referring physician plus the initial neuroradiologist and a dedicated ERN-RND neuroradiological expert clinician (and further experts if necessary. Meetings are facilitated by the ERN-RND CPMS helpdesk.


You are affiliated to an ERN-RND expert center and would like to receive neuroradiology advice for one of your patients?
Please
contact us.
Online Multidisciplinary Board for Deep Brain Stimulation in Dystonia
ERN-RND has established a standard pathway for providing multidisciplinary expert recommendations concerning Deep Brain Stimulation (DBS) in Dystonia.

Potential questions which the multidisciplinary board may address include (but are not limited to):

    1. Indication: DBS candidate yes/no?
    2. Target: Which Target; GPi, STN, VoA?
    3. Programming: Treatment advices of implanted patients
To make use of this opportunity, relevant medical data must be provided via the telemedicine platform CPMS beforehand.
Advice will be provided by at minimum one dystonia expert specialized in DBS and a stereotactic surgeon specialized in DBS, plus further specialists invited case-by-case in a virtual meeting with the referring clinician.
Meetings are facilitated by the ERN-RND CPMS helpdesk.

ERN VIDEO: GENETICS AND INHERITANCE

Explanatory Video on Genetics and Inheritance by ERN-CRANIO
This video explains the basics of genetics and inheritance, giving you examples of how conditions can be inherited and how DNA works. It is a general video and not focused on ERN-CRANIO diseases.

UPCOMING EVENTS

ERICA 4th General Assembly & ERN Research Conference
11- 13 December, 2024, in Udine, Italy


The aim of the ERICA consortium, in which all 24 European Reference Networks (ERNs) take part, is to build on the strength of the individual ERNs and create a platform that integrates all ERNs research and innovation capacity. ERICA Conference serves as a great opportunity to ‘meet and greet’ the active ERN research community, to present the research projects involving ERNs and to discuss the future of the ERN related research.

Online registration is still possible. Preliminary Programme here.
International Symposium
Neurodevelopmental Syndromes and Movement Disorders
6-7 February 2025, in Barcelona, Spain


This event is dedicated to:
  • Neurobiological basis of neurodevelopmental and movement disorders
  • Neurodevelopment and neurodegeneration
  • Behavioral abnormalities in movement disorders
  • Neurodevelopmental and epileptic encephalopathies
  • Movement disorders and comorbidities across the lifespan


Early bird registration till December 16. Find the programme here.
EAN 2025
11th Congress of the European Academy of Neurology
June 21-24, Helsinki and online
The overarching theme for the EAN Congress 2025 in Helsinki explores the multifaceted relationship between neurology and society. The topic particularly challenges our practice since our society impacts the progress, priorities, and relevance of neurology, and, conversely, neurology influences decisions and developments in society. This creates a highly complex and consequential set of interactions that affect all of us - professionals and patients alike.

For abstract submission click here and for Information on theme-related workshops here.


EACD & IAACD 2025
37th Annual Meeting of EACD & 4th Triennial Meeting of IAACD
June 24-28, Heidelberg, Germany and Online
The combined congress of the European Academy of Childhood Disability together with the International Alliance of Academies of Childhood Disability (EACD-IAACD) will be a hybrid event.The online transmission during daytime will also be supported by 24hour-online live sessions on 26th and 27th June enabling for the first time active worldwide participation.

To register click here.
EPNS 2025
16th European Paediatric Neurology Society Congress
July 8-12, Munich, Germany


The 16th EPNS Munich Congress will classify the field into A for acute, B for Brain, Health & Science and C for Chronic. This way an own alphabet of research and care taking is created: dedicated to the children, equipped for the extending variety of neuropaediatric diseases, stimulating and integrating science.

Deadline for submissions is the 15th January 2025. Find more Information here.

NEWSLETTER

The ERN-RND Newsletter is published monthly. Please forward this newsletter to your colleagues who can also sign up to receive it directly here or by emailing communication@ern-rnd.eu
Thank you for your support and take care.

Kind regards,
ERN-RND Coordination team
10_ERN_Banner_Neurological
website twitter youtube facebook linkedin 
Email Marketing Powered by MailPoet